Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Ovarian Neoplasms 5Hematologic Neoplasms 5Neoplasms 4Prostatic Neoplasms 2Multiple Myeloma 2Lung Neoplasms 2Hematopoietic and Lymphatic System Neoplasm 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Breast Neoplasms 2Weight Cycling 1Vulvar Neoplasms 1Vaginal Neoplasms 1Triple Negative Breast Neoplasms 1Tobacco Use Disorder 1Tobacco Use Cessation 1Substance-Related Disorders 1Smoldering Multiple Myeloma 1Smoking Cessation 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Obesity-Related Malignant Neoplasm 1Neoplasm Metastasis 1Motor Activity 1Mental Disorders 1Insulin Resistance 1Hematopoietic and Lymphoid System Neoplasm 1Head and Neck Neoplasms 1Head and Neck Carcinoma 1Genital Neoplasms, Female 1

Interventions

enzalutamide 92Magnetic Resonance Spectroscopy 87Specimen Handling 66Prednisone 65Androgen Antagonists 59Abiraterone Acetate 59apalutamide 56Radiosurgery 53Radiotherapy 47Leuprolide 47darolutamide 46abiraterone 44Docetaxel 43Radiation 31Pluvicto 31acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 30Biopsy 30relugolix 28Surveys and Questionnaires 28pembrolizumab 26gallium 68 PSMA-11 26Standard of Care 26Triptorelin Pamoate 25Goserelin 25bicalutamide 23Gonadotropin-Releasing Hormone 23Brachytherapy 21Carboplatin 20X-Rays 19luprolide acetate gel depot 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Behavior Therapy × 1 year × Clear all
NCT07377006 2026-02-18

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
108 enrolled
Genitourinary

Prostatic Neoplasms

NCT07202247 2026-02-04

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

City of Hope Medical Center

Phase 2 Recruiting
60 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡